IPSEN PORTUGAL secures contract for Acquisition Of Cabozantinib Oral 60Mg Comp Rev (Aue 202600846) From Lab Ipsen To Ulsasi For The Year 2026

Portugal, April 1 -- Portugal based IPSEN PORTUGAL has secured contract from Unidade Local De Saude De Amadora/Sintra, Epe for Acquisition Of Cabozantinib Oral 60Mg Comp Rev (Aue 202600846) From Lab Ipsen To Ulsasi For The Year 2026. The value of the contract is worth 3500000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....